FDA

Elon Musk’s Neuralink, a brain implant company, announced on Wednesday that it has begun recruiting people for its first human trial. The company's goal is to connect human brains to computers, and it wants to test its technology on people...

Health officials in the US have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers. The Food and Drug Administration on Friday granted approval of the drug, Zurzuvae, for...

The U.S. Food and Drug Administration on Thursday granted full approval to the Biogen and Eisai Alzheimer’s treatment Leqembi. Leqembi, also known as lecanemab, is the first drug shown to slow the progress of the disease, rather than just treating...

Elon Musk's brain-implant company Neuralink on Thursday said it had received the US Food and Drug Administration's (FDA) approval to launch its first in-human clinical study. The company announced the decision on Twitter, saying the approval "represents an important first...

The Food and Drug Administration (FDA) turned down a bid from Neuralink, the human brain chip startup founded by Elon Musk, to begin human trials, Reuters reported Thursday. In explaining the decision to Neuralink, the agency outlined dozens of issues...

A newly developed biomaterial that is capable of being injected intravenously may decrease inflammation in tissue while also promoting the healing of both cells and tissue. Both rodent and big animal models were utilized to evaluate the efficacy of the...

Bexacat, the first FDA-approved orally administered drug for diabetic cats that have not already received insulin treatment, will be available in the United States soon. The drug, in the form of bexagliflozin tablets, is intended specifically for cats with...

A Greek, born and bred in Thessaloniki, is offering the world a wonder drug. No, his name is not Albert Bourla of Pfizer. Stelios Papadopoulos of Biogen will help millions with Alzheimer's.

The FDA has approved a new drug shown to slow down the early stages of Alzheimer’s despite controversy surrounding some of its more serious side effects. Lecanemab, the first drug to actively decelerate the progress of the disease, seems to...

  On Wednesday, the U.S. Food and Drug Administration (FDA) authorized two freshly revised COVID-19 boosters: one created by Moderna and one by Pfizer and German biotechnology company BioNTech. The original SARS-CoV-2 coronavirus variant, which was the target of the first...